Please share your current experiences at [email protected]
In 2024, 26 or 52% of the 50 new medicines approved by CDER were for orphan-designated indications
Patients using Wegovy for weight management may have pre-existing cardiovascular risk factors (hypertension, dyslipidaemia, type 2 diabetes)
This prescription medication acts on multiple hormone receptors offering a unique approach to reducing appetite and promoting weight loss
Detailed Category Analysis# Receptor Targets# Retatrutide : Triple agonist: GIP, GLP-1, and glucagon receptors simultaneously Tirzepatide : Dual agonist: GIP and GLP-1 receptors Advantage : Retatrutide Weight Loss Efficacy# Retatrutide : Up to 28.7% body weight reduction at 68 weeks (Phase 3 TRIUMPH-4)
Ginger tea, ginger chews, or fresh ginger added to smoothies can reduce nausea enough to make eating tolerable